Immunoglobulin G/immunoglobulin M autoantibody ratios in incomplete systemic lupus erythematosus

S HenningJ WestraC RoozendaalG Haarsma-de BoerJJ FierroB HorvathH BootsmaK de Leeuw1 Departments of Rheumatology and Clinical Immunology,University Medical Centre Groningen,Groningen,The Netherlands2 Department of Laboratory Medicine,University Medical Centre Groningen,Groningen,The Netherlands3 Reproduction Group,Department of Microbiology and Parasitology,University of Antioquia UdeA,Medellin,Colombia4 Departments of Dermatology,University Medical Centre Groningen,Groningen,The Netherlands

DOI: https://doi.org/10.1080/03009742.2024.2321700

2024-03-20

Scandinavian Journal of Rheumatology

Abstract:Objective Immunoglobulin G (IgG) autoantibodies in systemic lupus erythematosus (SLE) are considered pathogenic, whereas immunoglobulin M (IgM) autoantibodies may have protective effects. The aim of this study was to identify whether IgG/IgM autoantibody ratios differ between patients with incomplete systemic lupus erythematosus (iSLE), patients with SLE, and healthy controls (HCs), and whether IgG/IgM autoantibody ratios relate to progression from iSLE to SLE.

rheumatology

What problem does this paper attempt to address?

The problem this paper attempts to address is:

Systemic lupus erythematosus (SLE) is a heterogeneous autoimmune disease that primarily affects women of childbearing age and can manifest as skin rashes, arthritis, and life-threatening organ damage. Despite significant progress in understanding the pathogenesis of SLE, little is known about its early stages. Incomplete systemic lupus erythematosus (iSLE) patients exhibit symptoms similar to SLE but are insufficient for an SLE diagnosis. Some of these patients may develop SLE within a few years, while others may continue to exhibit mild symptoms or develop other autoimmune diseases.

Therefore, the main objectives of this study are to evaluate:
1. **Whether the IgG/IgM autoantibody ratio is higher in iSLE patients compared to healthy controls**.
2. **Whether the IgG/IgM ratio is associated with interferon scores and clinical parameters**.
3. **Whether the IgG/IgM ratio is related to the progression from iSLE to SLE**.

Specifically, the researchers focused on the IgG and IgM levels of three autoantibodies: anti-dsDNA, anti-Ro52, and anti-Ro60, and explored the changes in these ratios in iSLE patients and their relationship to disease progression. Through these analyses, the researchers hope to identify biomarkers that can predict whether iSLE patients will progress to SLE.